Cardiovascular Risk Factors in Patients with Valvular Heart Disease: A Nationwide Observational Cohort Study
Qianhong Lu,Junxing Lv,Zhe Li,Yunqing Ye,Bin Zhang,Weiwei Wang,Qinghao Zhao,Haitong Zhang,Zhenyan Zhao,Bincheng Wang,Qingrong Liu,Zikai Yu,Zhenya Duan,Shuai Guo,Yanyan Zhao,Runlin Gao,Haiyan Xu,Yongjian Wu
DOI: https://doi.org/10.2147/ijgm.s498982
IF: 2.145
2024-11-29
International Journal of General Medicine
Abstract:Qianhong Lu, 1, 2, &ast Junxing Lv, 1– 4, &ast Zhe Li, 1, 2 Yunqing Ye, 1, 2 Bin Zhang, 1, 2 Weiwei Wang, 1, 2 Qinghao Zhao, 1, 2 Haitong Zhang, 1, 2 Zhenyan Zhao, 1, 2 Bincheng Wang, 1, 2 Qingrong Liu, 1, 2 Zikai Yu, 1, 2 Zhenya Duan, 1, 2 Shuai Guo, 1, 2 Yanyan Zhao, 1, 5 Runlin Gao, 1, 2 Haiyan Xu, 1, 2 Yongjian Wu 1, 2 On behalf of the CHINA-VHD collaborators 1 Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, People's Republic of China; 2 Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100037, People's Republic of China; 3 Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, 200032, People's Republic of China; 4 Cardiovascular Technology and Device Innovation Unit, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, People's Republic of China; 5 Medical Research & Biometrics Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100037, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yongjian Wu; Haiyan Xu, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, Xicheng District, Beijing, 100037, People's Republic of China, Email ; Purpose: Conventional cardiovascular risk factors may contribute to the development of valvular heart disease (VHD). The present study sought to investigate the distribution of conventional modifiable cardiovascular risk factors (smoking, hypertension, hyperlipidemia, and diabetes) in various VHDs, the impact of risk factors on outcomes, and the prognostic indicators in patients with distinct burdens of risk factors. Patients and methods: The study included 11862 patients with moderate or greater VHD. The primary outcome was a composite of all-cause mortality, hospitalization for heart failure, and myocardial infarction within two years. Results: Of 11862 patients with VHD, the mean age was 61.77 ± 13.51 years, and 44.4% were female. The prevalences of smoking, hypertension, hyperlipidemia, and diabetes were 14.9%, 45.0%, 13.4%, and 14.5% in the total cohort. Patients with zero, one, two, three, or four risk factors accounted for 39.4%, 38.2%, 17.7%, 4.3%, and 0.3%, respectively. The number of conventional risk factors was independently associated with two-year outcome in patients with mitral regurgitation (MR; three/four vs zero: hazard ratio [HR, 95% confidence interval (CI)]: 1.600 [1.106– 2.315], P = 0.013; two vs zero: HR [95% CI]: 1.153 [0.867– 1.532], P = 0.328; one vs zero: HR [95% CI]: 0.892 [0.687– 1.159], P = 0.393). Stratified by the etiology of mitral valve lesions, each one risk factor increase was independently related to a 17.3% higher risk of adverse events in secondary MR. In patients with three or four risk factors, females had a significantly poorer outcome than males (P = 0.002). Conclusion: More than one of five VHD patients had at least two conventional cardiovascular risk factors. The increasing number of risk factors indicated poor prognosis in patients with significant MR. Optimizing risk factor control may improve secondary prevention as well as long-term outcomes of VHD. Keywords: valvular heart disease, secondary prevention, mitral regurgitation, risk factor Globally, valvular heart disease (VHD) is an enormous health burden. 1,2 Over the past two decades, a series of novel transcatheter techniques have emerged for treating different types of valvular diseases, providing definitive therapies for eligible patients previously considered surgically inoperable. 3–5 However, a large number of VHD patients still have a high risk of worsening heart failure or mortality, even after a successful correction of valvular lesions, 5–7 which may be attributed to the irreversible global cardiac damage and remodeling. 7 Importantly, such cardiac impairments can not only be induced by the long-term VHD-related hemodynamic abnormality 8 but also related to other pathophysiologic -Abstract Truncated-
medicine, general & internal